Daniel Marquez-Marquez

Dr. Daniel Marquez-Marquez

Griffith University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in Sensors
Verified
Journal Article
Open access
PDF file
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
SPSravan Pingali
Sravan Pingali
Kriengsak PanuwatwanichKriengsak Panuwatwanich
Kriengsak Panuwatwanich
Rodney StewartRodney Stewart
Rodney Stewart
Sherif MohamedSherif Mohamed
Sherif Mohamed
Most accidents in the aviation, maritime, and construction industries are caused by human error, which can be traced back to impaired mental performance and attention failure. In 1596, Du Laurens, a French anatomist and medical scientist, said that the eyes are the windows of the mind. Eye tracking research dates back almost 150 years and it has been widely used in different fields for several purposes. Overall, eye tracking technologies provide the means to capture in real time a variety of eye movements that reflect different human cognitive, emotional, and physiological states, which can be used to gain a wider understanding of the human mind in different scenarios. This systematic literature review explored the different applications of eye tracking research in three high-risk industries, namely aviation, maritime, and construction. The results of this research uncovered the demographic distribution and applications of eye tracking research, as well as the different technologies that have been integrated to study the visual, cognitive, and attentional aspects of human mental performance. Moreover, different research gaps and potential future research directions were highlighted in relation to the usage of additional technologies to support, validate, and enhance eye tracking research to better understand human mental performance.

12 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
AMAli Mirnajafizadeh
Ali Mirnajafizadeh
CCChristopher P Carty
Christopher P Carty
Rodney StewartRodney Stewart
Rodney Stewart
3D printing is an emergent manufacturing technology recently being applied in the medical field for the development of custom bone prostheses and scaffolds. However, successful industry transformation to this new design and manufacturing approach requires technology integration, concurrent multi-disciplinary collaboration, and a robust quality management framework. This latter change enabler is the focus of this study. While a number of comprehensive quality frameworks have been developed in recent decades to ensure that the manufacturing of medical devices produces reliable products, they are centred on the traditional context of standardised manufacturing techniques. The advent of 3D printing technologies and the prospects for mass customisation provides significant market opportunities, but also presents a serious challenge to regulatory bodies tasked with managing and assuring product quality and safety. Before 3D printing bone prostheses and scaffolds can gain traction, industry stakeholders, such as regulators, clients, medical practitioners, insurers, lawyers, and manufacturers, would all require a high degree of confidence that customised manufacturing can achieve the same quality outcomes as standardised manufacturing. A Quality by Design (QbD) approach to custom 3D printed prostheses can help to ensure that products are designed and manufactured correctly from the beginning without errors. This paper reports on the adaptation of the QbD approach for the development process of 3D printed custom bone prosthesis and scaffolds. This was achieved through the identification of the Critical Quality Attributes of such products, and an extensive review of different design and fabrication methods for 3D printed bone prostheses. Research outcomes include the development of a comprehensive design and fabrication process flow diagram, and categorised risks associated with the design and fabrication processes of such products. An extensive systematic literature review and post-hoc evaluation survey with experts was completed to evaluate the likely effectiveness of the herein suggested QbD framework.

27 October 2020 in Materials
Verified
Journal Article
Open access
PDF file
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
Ylva DelmarYlva Delmar
Ylva Delmar
Shoujin SunShoujin Sun
Shoujin Sun
Rodney StewartRodney Stewart
Rodney Stewart
Additive manufacturing facilitates the design of porous metal implants with detailed internal architecture. A rationally designed porous structure can provide to biocompatible titanium alloys biomimetic mechanical and biological properties for bone regeneration. However, increased porosity results in decreased material strength. The porosity and pore sizes that are ideal for porous implants are still controversial in the literature, complicating the justification of a design decision. Recently, metallic porous biomaterials have been proposed for load-bearing applications beyond surface coatings. This recent science lacks standards, but the Quality by Design (QbD) system can assist the design process in a systematic way. This study used the QbD system to explore the Quality Target Product Profile and Ideal Quality Attributes of additively manufactured titanium porous scaffolds for bone regeneration with a biomimetic approach. For this purpose, a total of 807 experimental results extracted from 50 different studies were benchmarked against proposed target values based on bone properties, governmental regulations, and scientific research relevant to bone implants. The scaffold properties such as unit cell geometry, pore size, porosity, compressive strength, and fatigue strength were studied. The results of this study may help future research to effectively direct the design process under the QbD system.

1 September 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
Karan GulatiKaran Gulati
Karan Gulati
CCChristopher P. Carty
Christopher P. Carty
Rodney StewartRodney Stewart
Rodney Stewart
Saso IvanovskiSaso Ivanovski
Saso Ivanovski

24 September 2019 in Materials
Verified
Journal Article
Open access
PDF file
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
MJMilda Jokymaityte
Milda Jokymaityte
AMAli Mirnajafizadeh
Ali Mirnajafizadeh
CCChristopher P. Carty
Christopher P. Carty
DLDavid Lloyd
David Lloyd
Rodney StewartRodney Stewart
Rodney Stewart
Unlike subtractive manufacturing technologies, additive manufacturing (AM) can fabricate complex shapes from the macro to the micro scale, thereby allowing the design of patient-specific implants following a biomimetic approach for the reconstruction of complex bone configurations. Nevertheless, factors such as high design variability and changeable customer needs are re-shaping current medical standards and quality control strategies in this sector. Such factors necessitate the urgent formulation of comprehensive AM quality control procedures. To address this need, this study explored and reported on a variety of aspects related to the production and the quality control of additively manufactured patient-specific implants in three different AM companies. The research goal was to develop an integrated quality control procedure based on the synthesis and the adaptation of the best quality control practices with the three examined companies and/or reported in literature. The study resulted in the development of an integrated quality control procedure consisting of 18 distinct gates based on the best identified industry practices and reported literature such as the Food and Drug Administration (FDA) guideline for AM medical devices and American Society for Testing and Materials (ASTM) standards, to name a few. This integrated quality control procedure for patient-specific implants seeks to prepare the AM industry for the inevitable future tightening in related medical regulations. Moreover, this study revealed some critical success factors for companies developing additively manufactured patient-specific implants, including ongoing research and development (R&D) investment, investment in advanced technologies for controlling quality, and fostering a quality improvement organizational culture.

1 January 2019 in Procedia Manufacturing
Verified
Journal Article
Open access
Daniel Marquez-MarquezDaniel Marquez-Marquez
Daniel Marquez-Marquez
AMAli Mirnajafizadeh
Ali Mirnajafizadeh
CCChristopher P. Carty
Christopher P. Carty
RSRodney A. Stewart
Rodney A. Stewart